AR036891A1 - Rosuvastatina en estados predemenciales - Google Patents

Rosuvastatina en estados predemenciales

Info

Publication number
AR036891A1
AR036891A1 ARP020103895A ARP020103895A AR036891A1 AR 036891 A1 AR036891 A1 AR 036891A1 AR P020103895 A ARP020103895 A AR P020103895A AR P020103895 A ARP020103895 A AR P020103895A AR 036891 A1 AR036891 A1 AR 036891A1
Authority
AR
Argentina
Prior art keywords
rosuvastatina
predemential
states
patient
dementia
Prior art date
Application number
ARP020103895A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR036891A1 publication Critical patent/AR036891A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)

Abstract

Método para evitar la demencia en un paciente que comprende administrar a un paciente que corre riesgo de desarrollar demencia una cantidad efectiva de rosuvastatina o su sal farmacéuticamente aceptable
ARP020103895A 2001-10-19 2002-10-17 Rosuvastatina en estados predemenciales AR036891A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103509A SE0103509D0 (sv) 2001-10-19 2001-10-19 Rosuvastatin in pre demented states

Publications (1)

Publication Number Publication Date
AR036891A1 true AR036891A1 (es) 2004-10-13

Family

ID=20285721

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103895A AR036891A1 (es) 2001-10-19 2002-10-17 Rosuvastatina en estados predemenciales

Country Status (19)

Country Link
US (1) US20060229321A1 (es)
EP (1) EP1446123A1 (es)
JP (1) JP2005505605A (es)
KR (1) KR20040058201A (es)
CN (1) CN1604780A (es)
AR (1) AR036891A1 (es)
BR (1) BR0213434A (es)
CA (1) CA2463597A1 (es)
CO (1) CO5580773A2 (es)
HU (1) HUP0401798A3 (es)
IL (1) IL161380A0 (es)
IS (1) IS7218A (es)
MX (1) MXPA04003631A (es)
NO (1) NO20041840L (es)
PL (1) PL369573A1 (es)
RU (1) RU2004112422A (es)
SE (1) SE0103509D0 (es)
WO (1) WO2003032995A1 (es)
ZA (1) ZA200402844B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2657076A1 (en) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Process for the preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
CA2546701C (en) 2003-11-24 2010-07-27 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
WO2005056534A1 (en) 2003-12-02 2005-06-23 Teva Pharmaceutical Industries Ltd. Reference standard for characterization of rosuvastatin
WO2006017357A1 (en) 2004-07-13 2006-02-16 Teva Pharmaceutical Industries Ltd. A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
JP4713574B2 (ja) 2005-02-22 2011-06-29 テバ ファーマシューティカル インダストリーズ リミティド ロスバスタチンアルキルエーテルを含まないロスバスタチンおよびその塩およびそれらを製造する方法
EP1805148A2 (en) 2005-08-16 2007-07-11 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
WO2012073256A1 (en) 2010-11-29 2012-06-07 Cadila Healthcare Limited Salts of rosuvastatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
AR022462A1 (es) * 1999-02-06 2002-09-04 Astrazeneca Uk Ltd Uso de un agente que disminuye el colesterol
US20030100493A1 (en) * 2001-07-19 2003-05-29 Sol Weiss Sublingual use of inhibitors in the biosynthesis of cholesterol

Also Published As

Publication number Publication date
WO2003032995A8 (en) 2004-06-03
PL369573A1 (en) 2005-05-02
WO2003032995A1 (en) 2003-04-24
MXPA04003631A (es) 2004-07-30
HUP0401798A3 (en) 2005-06-28
BR0213434A (pt) 2004-11-09
IL161380A0 (en) 2004-09-27
NO20041840L (no) 2004-05-05
CN1604780A (zh) 2005-04-06
HUP0401798A2 (hu) 2005-01-28
JP2005505605A (ja) 2005-02-24
ZA200402844B (en) 2005-01-24
CO5580773A2 (es) 2005-11-30
CA2463597A1 (en) 2003-04-24
EP1446123A1 (en) 2004-08-18
US20060229321A1 (en) 2006-10-12
SE0103509D0 (sv) 2001-10-19
RU2004112422A (ru) 2005-04-10
KR20040058201A (ko) 2004-07-03
IS7218A (is) 2004-04-13

Similar Documents

Publication Publication Date Title
ES2545205T3 (es) Combinación de azelastina y ciclesonida
AR013488A1 (es) COMPOSICIoN GERMICIDA ACUOSA PARA EL TRATAMIENTO O PREVENCIoN DE ENFERMEDADES INFECCIOSAS DE LAS PEZUNAS DE ANIMALES, Y USO DE DICHA COMPOSICIoN
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
CY1106283T1 (el) Κινολινυλ-πυρρολοπυραζολες
MEP42808A (en) Use of flibanserin in the treatment of sexual disorders
FI20012017A (fi) Menetelmä ja laite magneettistimulaation annoslaskentaa varten
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
HRP20040758B1 (hr) Uporaba il-18 inhibitora za lijeäśenje i/ili prevenciju perifernih krvožilnih bolesti
CY1110385T1 (el) Χρηση αναστολεων της il-18 για τη θεραπεια και/ή προληψη της αθηροσκληρωσης
PT840601E (pt) Thip para o tratamento de desordens do sono
ITTO20040621A1 (it) Immunogeno sintetico per la terapia e profilassi dell'abuso di droghe e sostanze psicoattive
DE50301661D1 (de) Darreichungsform von Ibuprofen-Natrium
DK0699439T3 (da) Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer
AR036891A1 (es) Rosuvastatina en estados predemenciales
NO20015122L (no) Behandling av fibrose ved anvendelse av en antagonist for integrin <alfa>-4-subenheten
DOP2001000268A (es) Derivados puente de piperazina
EA199901043A1 (ru) ИНГИБИТОРЫ ФАРНЕЗИЛТРАНСФЕРАЗЫ В КОМБИНАЦИИ С ИНГИБИТОРАМИ HMG-CoA-РЕДУКТАЗЫ ДЛЯ ЛЕЧЕНИЯ РАКА
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
ME00489B (me) NOVA SINERGIČKA KOMBINACIJA KOJA UKLJUČUJE ROFLUMILAST l FERMOTEROL
SE0004827D0 (sv) Therapeutic compounds
BR0015404A (pt) Compostos relacionados com ácido 15-hidroxieicosatetraenóico e métodos de uso
BR9809376A (pt) Pregnan-3-ol-20-onas
CR7819A (es) Unidad para dosificacion diaria de melatonina
AR026243A1 (es) Solucion oral de galantamina
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12

Legal Events

Date Code Title Description
FA Abandonment or withdrawal